Appendix
ABSTRACT
For access to the full length article, please sign in.
Appendix
Compiled by Ali McBride, PharmD, BCOP, Andrew Garcia, PharmD, and Alyssa Hinchman, PharmD
The University of Arizona Cancer Center, Tucson, Arizona
Dr. McBride has served on speakers bureaus for AbbVie and Incyte. Dr. Garcia and Dr. Hinchman have no potential conflicts of interest to disclose.
Ali McBride, PharmD, MS, BCPS, BCOP, The University of Arizona Cancer Center, 3838 N. Campbell Avenue, PO Box 245219, Tucson, AZ 85719. E-mail: Ali.McBride@uahealth.com
J Adv Pract Oncol 2017;8:123-156 | https://doi.org/10.6004/jadpro.2017.8.7.21 | © 2017 Harborside™
The University of Arizona Cancer Center, Tucson, Arizona
Dr. McBride has served on speakers bureaus for AbbVie and Incyte. Dr. Garcia and Dr. Hinchman have no potential conflicts of interest to disclose.
Ali McBride, PharmD, MS, BCPS, BCOP, The University of Arizona Cancer Center, 3838 N. Campbell Avenue, PO Box 245219, Tucson, AZ 85719. E-mail: Ali.McBride@uahealth.com
J Adv Pract Oncol 2017;8:123-156 | https://doi.org/10.6004/jadpro.2017.8.7.21 | © 2017 Harborside™
ABSTRACT
Appendix. Treatment Regimens for Chronic Lymphocytic Leukemia
For access to the full length article, please sign in.